title: Drug therapy of inflammatory bowel disease in fertile women.
abstract: Inflammatory bowel disease (IBD) is a disease that affects women of childbearing age. Active disease at conception increases the risk for adverse outcomes and thus postponement of pregnancy until the disease is in remission is the best advice that physicians can give their IBD patients. The majority of medications used to treat IBD are safe in pregnancy and breastfeeding; active, untreated, or undertreated disease is more deleterious than active therapy.
authors.affiliation: Clinical Associate Professor of Medicine, Drexel University College of Medicine, Philadelphia, Pennsylvania 19107, USA.
authors.forename: Joyann
authors.initials: J
authors.lastname: Kroser
authors.forename: Radhika
authors.initials: R
authors.lastname: Srinivasan
mesh_terms: D005260:Female; D005298:Fertility; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy*; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy; D019936:Probiotics / Q000627:therapeutic use
chemical_list: D007155:Immunologic Factors